Our next #wvcdc interview is now live, featuring Candice Decaire of @AAHITweets! Hear about the team's proposal for a #network of innovators.
#vaccinenation #vaccine #technology #globalhealth #innovation #aahi
vaccinenation.org/global-health/infrastructure-for-innova…
Infectious Disease Research Institute
The Infectious Disease Research Institute (IDRI) was a non-profit organization based in Seattle, in the United States, and which conducts global health research on infectious diseases. Its new name is Access to Advanced Health Institute (AAHI). More on Wikipedia
-
AAHI reposted
World Vaccine Congress
@vaccinenation
-
AAHI reposted
Prof Peter Hotez MD PhD DSc(hon)
@PeterHotez
Latest from our @TexasChildrens vaccine center in collaboration with @AAHITweets in Seattle WA
Choice of Adjuvant and Antigen Composition Alters the Immunogenic Profile of a SARS-CoV-2 Subunit Vaccine www.frontiersin.org/articles/10.3389/fddev.2024.1342518 -
AAHI
@AAHITweets
Congratulations Curevo team on recent human clinical trial results demonstrating its #shingles vaccine candidate, CRV-101, elicits a 100% vaccine response rate.
We are thrilled to support the team by providing our SLA-SE #adjuvant formulation, a critical component of CRV-101. -
AAHI
@AAHITweets
As pandemic raged, global south lacked vaccines. Never again, researchers vow. www.washingtonpost.com/health/2023/07/16/vaccines-mrna-gl…
-
AAHI reposted
MEDICONmm
@MEDICONmm
Dr Will Lykins @AAHITweets presenting talk on Pre-clinical optimisation of adjuvant formulation, route and regimen of SARS-SoV-2 subunit vaccine at MEDICONmm/mvads_2023 in Copenhagen
-
AAHI reposted
Making Sense of Science
@MkngSenseOfSci
Tardigrades can be dried, frozen, boiled, irradiated-and still survive. Scientists study their secrets to make medicines that don’t require refrigeration. That would be a gamechanger for hot climates & places w/ unreliable electricity @UWyonews @AAHITweets leaps.org/tardigrades/
-
AAHI reposted
David Wallace-Wells
@dwallacewells
“Our efforts should shift to measures required for facing Covid-19 as a long-term cause of human illness, suffering and death, not a short-term catastrophe.” www.nytimes.com/2023/05/09/opinion/covid-emergency-over.html
-
AAHI
@AAHITweets
Made possible by #adjuvant technology!
Helen Branswell 🇨🇦
@HelenBranswell
It's taken decades, but there is finally a vaccine to protect against serious disease from #rsv. This one's for adults 60 and older, from #gsk. Options for protecting infants coming later this year. www.statnews.com/2023/05/03/fda-approves-rsv-vaccine-gsk/
-
AAHI
@AAHITweets
AAHI is committed to developing safe and durable #adjuvant intranasal vaccines with the support of the @NIH, @3M, and other partners. @dr_kkjetelina & @ENirenberg yourlocalepidemiologist.substack.com/p/hype-or-hope-nasal…
-
AAHI reposted
Global Schistosomiasis Alliance
@elimin8schisto
Sm-p80 - SchistoShield®️ is a defined molecular #vaccine for intestinal #schistosomiasis. This vaccine💉 is based on a recombinant antigen, Sm-p80, that is easily accessible to the host's immune system. Now in phase 1 clinical trials.
#beatschisto #wiw2023
clinicaltrials.gov/ct2/show/NCT05292391 -
AAHI reposted
Molly R Coddington
@molcoddington
The use of shark-derived squalene as a vaccine product is not sustainable and impacts shark welfare. Researchers from @AAHITweets have found a way to create analogues of shark-derived squalene, with a helping hand from yeast fermentation.
@Tech_Networks
www.technologynetworks.com/vaccines/blog/shark-sourced-va… -
AAHI
@AAHITweets
One week away until the World Vaccine Congress Washington #wvcdc! Check out AAHI's intro video and connect with us directly or stop by booth #805 to learn more about how we develop accessible and equitable health solutions.
@vaccinenation
www.aahi.org/aahi-attends-world-vaccine-congress-2023/ -
AAHI
@AAHITweets
By doubling down on efforts to end TB, we can save millions of lives and trillions of dollars. AAHI joins forces with like-minded partners to overcome health inequities to end TB.
#worldtbday #endtb #tuberculosis
AAHI
@AAHITweets
-
AAHI
@AAHITweets
AAHI take a pragmatic and creative approach to develop equitably accessible TB vaccines, recognizing that a vaccine makes little or no impact is it is unaffordable and cannot be distributed to people who need it. #worldtbday
Read more - www.aahi.org/aahi-collaborates-to-protect-against-tubercu… -
AAHI
@AAHITweets
TB is a leading infectious disease killer and infects 25% of the global population. TB is most common in low resource areas of the world. AAHI is dedicated to ending the TB epidemic by tackling health inequities to ensure a healthy life for all.
#worldtbdayPost not available here, view on X
AAHI
@AAHITweets
AAHI
@AAHITweets
-
AAHI
@AAHITweets
Check out @NatureComms Editors' Highlights that showcase the 50 best papers recently published in micorbiology and infectious diseases www.nature.com/collections/jedgcgeija
-
AAHI reposted
World Vaccine Congress
@vaccinenation
We are delighted to announce the exhibitors featuring at World Vaccine Congress Washington 2023!
Don't miss out on this incredible opportunity to connect with industry leaders and stay up-to-date on the latest vaccine innovations.
Register from $445: secure.terrapinn.com/V5/step1.aspx?E=11122 -
AAHI reposted
From the Labs at Baylor College of Medicine
@BCMFromtheLabs
Interested in learning about the opportunities vs challenges of human #schistosomiasis #vaccines? Drs. @PeterHotez & @mebottazzi just published a paper on the topic. @bcmhouston @TCHResearchNews @TexasChildrens @bcm_gihep www.mdpi.com/2192926 #mdpitropicalmed @TropicalmedMDPI
-
AAHI
@AAHITweets
We are exhibiting at the World Vaccine Congress Washington #wvcdc! Join us for the largest meeting dedicated to vaccines, uniting vaccine experts and sharing ground-breaking technology @vaccinenation.
Meet with AAHI to learn more about our innovative vaccine platforms and mfg! -
AAHI reposted
Science in Seattle
@science_seattle
Big news! @AAHITweets has published the results of a Phase I #clinicaltrial demonstrating the safety and immunogenicity of a new, thermostable vaccine against #tuberculosis, the world’s second deadliest infectious disease. 🦠💉 www.genengnews.com/topics/drug-discovery/thermostable-tb-…
-
AAHI
@AAHITweets
Synthetic squalene: a sustainable alternative to shark? vaccinenation.org/technology/synthetic-squalene-a-sustain… via @vaccinenation
-
AAHI reposted
Genetic Engineering & Biotechnology News
@GENbio
Thermostable #tb Vaccine Found Safe and Immunogenic in Humans
Investigators say Phase I study represents a "major step forward for the field of thermostable lyophilized adjuvant-containing #vaccine candidates." Read more: www.genengnews.com/topics/drug-discovery/thermostable-tb-… #tuberculosis -
AAHI
@AAHITweets
A fantastic overview of the state of TB and the implications of the development of a thermostable TB vaccine candidate by @TheRobertHart
Forbes
@Forbes
Breakthrough For Tuberculosis—One Of The World’s Biggest Killers—As New Vaccine Shows Promise In Early Trials www.forbes.com/sites/roberthart/2023/03/06/breakthrough-f…
-
AAHI
@AAHITweets
[1/5] Results from a first-in-human clinical trial of our temp-stable single-vial adjuvanted subunit #tuberculosis vaccine candidate, supported by the @NIH showed the vaccine is safe and immunogenic in humans. The TB vaccine is stable for 3 months at 37°C www.aahi.org/press-release/the-access-to-advanced-health-…
Post not available here, view on X
AAHI
@AAHITweets
[4/5] What’s next for the TB vaccine candidate?
An important foundation for an equitable TB vaccine distribution is established by developing a temperature stable formulation. More studies are necessary to understand how immune responses translate to protection against disease.
AAHI
@AAHITweets
[5/5] The study was a collaborative effort made possible by AAHI and its partners: @SaintLouisU - Center for Vaccine Development, Lyophilization Technology Inc., @ABL_Inc, DF/Net REsearch, and @uiowa
-
AAHI reposted
The Scientist
@TheScientistLLC
An important vaccine ingredient is sourced from shark livers. But researchers might be one step closer to finding a more sustainable—and more effective—replacement. www.the-scientist.com/news-opinion/researchers-make-alter…
-
AAHI
@AAHITweets
[1/2] Researchers created over 20 shark squalene alternatives to be used as components of vaccine adjuvants, substances that enhance immune responses. In collaboration with @Amyris, AAHI engineered and evaluated sustainable alternatives to squalene with support from the @NIH
AAHI
@AAHITweets
[2/2] The study, published in @Nature_NPJ, is important because the development of sustainably sourced squalene alternatives enables vaccine adjuvant formulations that do not require shark-derived raw materials. #npjvaccines www.nature.com/articles/s41541-023-00608-y
-
AAHI reposted
Chemistry World
@ChemistryWorld
By swapping yeast for sharks, scientists have found a renewable source for squalene, an important and effective vaccine ingredient.
www.chemistryworld.com/news/the-hunt-is-on-for-vaccine-in… -
AAHI
@AAHITweets
6 women at AAHI share their journey in pursuing a career in science, their advice for young women looking to get into a STEM field, and what it is like to work at AAHI.
Take a listen –
www.aahi.org/aahi-celebrates-international-women-in-scien…
#womeninscience -
AAHI
@AAHITweets
We are thrilled to announce a new award from the @DeptofDefense's @DIU_x and @JPEOCBRND’s JPM #cbrn Medical team to develop and test prototype nasal spray for protection against a variety of respiratory diseases using AAHI's novel adjuvant formulations www.aahi.org/press-release/the-access-to-advanced-health-…
AAHI
@AAHITweets
The nasal spray will include AAHI’s formulation of two different adjuvants, SLA and 3M’s 3M-052 compound, which have been shown to protect against #influenza in vaccine candidates. If preclinical studies are successful, they will allow the progression to Phase 1 clinical trials
-
AAHI reposted
GeekWire
@geekwire
Seattle institute lands $9.9M to develop nasal spray vaccine against bird flu www.geekwire.com/2023/seattle-institute-lands-9-9m-to-dev…
-
AAHI
@AAHITweets
A nasal spray RNA vaccine may be key to a successful rapid response to pandemic #influenza outbreaks. We are excited to announce new funding from #dod and the JPM #cbrn Medical team and @BARDA to develop a prototype intranasal influenza vaccine on our #selfamplifyingrna platform
AAHI
@AAHITweets
Although influenza vaccines have been available for almost a century, three influenza pandemics have occurred since the 1918 H1N1 pandemic, of which the most recent 2009 pandemic claimed hundreds of thousands of lives worldwide in the first year. - www.aahi.org/press-release/the-access-to-advanced-health-…
-
AAHI
@AAHITweets
AAHI is proud to contribute its immune-enhancing platform technologies to develop preventive and therapeutic solutions to various neglected tropical diseases.
Read more -> www.aahi.org/about/our-impact/
#beatntds #equitableaccess #vaccinedevelopment #aahi -
AAHI
@AAHITweets
On #worldntdday, we recognize the 1 billion people who are affected by NTDs without access to clean water, sanitation, or sufficient health care suffering chronic symptoms of which devastate patients, handicap educational outcomes, and curtail opportunity.
Post not available here, view on X
AAHI
@AAHITweets
Act Now. Act Together. Invest in Neglected Tropical Diseases. #beatntds #worldntdday
AAHI
@AAHITweets
-
AAHI
@AAHITweets
Today is #worldleprosyday! Millions of people, concentrated in poverty-stricken tropical regions of Asia, Africa, and South America are living with leprosy-related disabilities.
AAHI
@AAHITweets
AAHI is dedicated to developing cost-effective and temperature-stable vaccines to provide equitably accessible health solutions to low-resource, rural, and remote parts of the world.
AAHI
@AAHITweets
We can eliminate transmission of #leprosy by 2030, if we collaborate and act now!
@WHO's global leprosy targets for 2030:
#beatleprosy -
AAHI
@AAHITweets
The PREVENT Pandemics Act will improve our #pandemic response strategy and coordination - supporting the development of next-generation vaccines, stockpiling medical products, and improving public health communication.
Senator Patty Murray
@PattyMurray
Time after time over the last few years, we saw how our response to this pandemic could have, and should have, been better. That's why I fought so hard to pass my bipartisan PREVENT Pandemics Act—legislation that helps build a strong public health system.
-
AAHI
@AAHITweets
Inhalable #vaccines has the potential to halt viral transmission, prevent early infection, and increase vaccine uptake. But successful development requires incredible precision of vaccine #formulations to be safe and effective.
www.pharmtech.com/view/inhalation-vaccine-development via @PharmTech -
AAHI
@AAHITweets
A universal #covid19 vaccine may protect us from pervasive emerging variants. Continued support for such next-generation vaccine solutions is essential.
CNN
@CNN
The US Centers for Disease Control and Prevention’s Covid-19 variant dashboard revealed a new dark horse that could soon sweep the field
www.cnn.com/2023/01/03/health/covid-variant-xbb-explainer… -
AAHI
@AAHITweets
A synthetic phospholipid component of AAHI's emulsion formulations, including SE, GLA-SE, and @3M-052-SE, stimulates the innate immune system without traditional adjuvants, like squalene, published in @MDPIpharma www.mdpi.com/1999-4923/14/12/2557/htm
AAHI
@AAHITweets
The findings are important because the immune stimulating effect could impact preclinical and toxicology studies unless accounted for. #formulations #biotechnology #vaccines
-
AAHI
@AAHITweets
How can we develop stable vaccines that can be shipped and stored without refrigeration?
Dr. Emily Voigt, Principal Scientist, shares our approach to developing a thermostable #covid19 vaccine candidate with @Tech_Networks www.technologynetworks.com/vaccines/articles/the-challeng… -
AAHI
@AAHITweets
Thank you, @GlobalWA, for hosting a wonderful Goalmaker’s Annual #conference2022 last week. We had a great time connecting with people aligned with our mission to develop equitably accessible health solutions.
Learn more about AAHI’s SDG progress today! www.aahi.org/wp-content/uploads/2022/12/SDG-Goal-Progress… -
AAHI
@AAHITweets
So grateful to share our mission at @GlobalWA’s Goalmaker’s Annual #conference22. We look forward to a day of forging new collaborations! Stop by our booth on the 3rd floor.
-
AAHI
@AAHITweets
Dr. @SalliePermar at @WeillCornell and Dr. Kristina De Paris at UNC find an adjuvanted #covid19 protein vaccine provides enhanced, longer lasting immunity than current mRNA vaccine technology in infant NHPs. @ScienceTM www.eurekalert.org/news-releases/973105
AAHI
@AAHITweets
[2/4] "Vaccine ajduvant technology is a highly valuable tool that can significantly extend the durability and breadth of our immune responses, reducing the need for frequent boosters." - Christopher Fox, SVP Formulations
AAHI
@AAHITweets
[3/4] "Special populations that don't have fully developed immune systems, such as young children, may particularly benefit from the appropriate use of adjuvants to increase vaccine efficacy" - Christopher Fox, SVP Formulations www.science.org/doi/10.1126/scitranslmed.add6383
AAHI
@AAHITweets
[4/4] Learn more about 3M-052-SE adjuvant, developed by @3M and formulated by AAHI, used in this preclinical study on @NIH's Vaccine Adjuvant Compendium vac.niaid.nih.gov/view?id=57
-
AAHI
@AAHITweets
Join us in two weeks at @GlobalWA's Galmakers Annual #conference2022 to discuss how we can build solutions for global health. #globaldevelopment
-
AAHI
@AAHITweets
We are excited to introduce our monthly newsletter to share the many ways in which we are working to develop equitably accessible vaccines and immunotherapies. Sign up today to learn about our journey to close the vaccine equity gap in a sustainable way! www.aahi.org/newsletter/
-
AAHI
@AAHITweets
Thank you to our scientists and staff for their compassion, creativity, and dedication, as they work every day to solve global health disparities and to our partners and collaborators for working with us to make equitable access to health solutions a reality. #happythanksgiving
-
AAHI
@AAHITweets
#malaria claims thousands of lives per year and is harder to eradicate. Researchers at Ehime University demonstrate #adjuvant formulations are a key component to developing an effective malaria #vaccine candidate published in @FrontiersIn Immunology #glase www.frontiersin.org/journals/immunology/articles/10.3389/…
-
AAHI
@AAHITweets
We are excited to participate in this year’s Goalmakers Annual Conference hosted by @GlobalWA to share innovative ways to collaborate and advance health equity.
Sign up today and join us at this premier event! globalwa.org/events-center/goalmakers-annual-conference-2…
#goalmakers2022 -
AAHI
@AAHITweets
"The protection against severity of disease is pretty good, but if you really want to suppress the virus by supressing acquisition as well as transmission, we have got to have better vaccines" Dr. Fauci tells @GENbio www.genengnews.com/insights/dr-fauci-reflects-on-his-54-y…
-
AAHI
@AAHITweets
The @WHO unveiled stark inequities in global vaccine accessibility. Today's vaccines are not suitable for lower-income countries and investment in vaccine technology that is simple to manufacture, thermostable, and more effective, may bridge the equity gap www.who.int/news/item/09-11-2022-who-releases-first-data-…
-
AAHI
@AAHITweets
A wonderful depiction of adjuvant technology and how adding an adjuvant in a vaccine can expand access to high-risk populations and to people in situations where vaccines are too expensive or in short supply. Adjuvants enable #equitable access to vaccines.
Molly R Coddington
@molcoddington
It’s a balancing act for scientists to create vaccines that are immunogenic (i.e., they trigger a sufficient immune response) and also safe. Adjuvants can offer a solution here, enhancing a vaccine's efficacy.
go.technologynetworks.com/vaccine-adjuvants -
AAHI
@AAHITweets
Adjuvants are molecules in a vaccine that "wake up" your immune system to enhance the protection the vaccine provides. @3M-052 adjuvant formulations are highly effective against rapidly mutating viruses such as #hiv, #influenza, and #covid19. Learn more - www.aahi.org/products-services/adjuvant-platform/
-
AAHI
@AAHITweets
Access to COVID-19 resources for surveillance and treatment is limited as we enter winter expecting to a boost in transmission. The immunocompromised remain the most vulnerable - @DrewQJoseph, @Jasonmmast www.statnews.com/2022/11/10/third-covid-winter-without-ke… via @statnews
-
AAHI reposted
World Health Organization (WHO)
@WHO
Vaccines are public health powerhouses that markets alone cannot deliver for all.
Featuring the first data of their kind since #covid19, WHO's Global Vaccine Market Report calls for action to provide equitable access to these life-saving public goods www.who.int/news/item/09-11-2022-who-releases-first-data-… -
AAHI
@AAHITweets
The successful lyophilization of our thermostable TB vaccine candidate was published today in @FrontiersIn Drug Discovery. The vaccine is stable in sub-Saharan African temperatures for 3 mos enabling last-mile vaccine delivery #lti @uwdgh @OAUniversity www.frontiersin.org/articles/10.3389/fddev.2022.1043756/full
-
AAHI
@AAHITweets
Make your way to Session 2 to listen to Dr. Emily Voigt's presentation on the development of an #intranasal RNA vaccine against #covid19. Those of you tuning in virtually and interested in learning more, get in touch with our team today! www.aahi.org/contact/
International mRNA Health Conference
@mrnaconference
Session 2:
Advances in Prophylactic Vaccines
Bali Pulendran - Standford Univ
Kelly Lindert - Arcturus
Robin Shattock - Imperial College, London
Wensheng Wei - Peking University
Emily Voigt - Acc to Adv Health Institute
Andrzej Dziembowski - Warsaw U
Dan Peer - Tel Aviv U -
AAHI
@AAHITweets
"Better vaccines are still needed...And the world needs a more equitable way of distributing vaccines" www.statnews.com/2022/11/03/how-the-world-can-end-covid-1… via @statnews
AAHI
@AAHITweets
The Delphi Consensus provides recommendations of 386 public health experts from 112 countries to end the COVID-19 public health threat published in @Nature www.nature.com/articles/s41586-022-05398-2
-
AAHI
@AAHITweets
Next-generation vaccine development may finally put the pandemic to rest. Our SVP, Formulations, Christopher Fox, tells @KnowableMag adjuvant technology may be the solution for potent, broadly protective, and long lasting vaccines.
knowablemagazine.org/article/health-disease/2022/what-nex… -
AAHI
@AAHITweets
Preclinical studies demonstrate new RNA #covid-19 vaccine using a novel formulation approach induces potent and broad immune responses and can be freeze-dried to provide stability at room temp for 6 mos. and refrigeration for 10 mos. @ImmunityBio @Amyris www.businesswire.com/news/home/20221102005965/en/The-Acce…
AAHI
@AAHITweets
This RNA vaccine candidate, AAHI-SC2, developed on AAHI’s RNA platform does not require a robust cold-chain for storage and transport, an issue when delivering to low-resource areas that lack this infrastructure. #vaccineequity
-
AAHI
@AAHITweets
AAHI will be attending the 10th International mRNA Health Conference next week! Contact us through our website aahi.org to learn more. #mrnahealthconference #mrna22
AAHI
@AAHITweets
Don't miss Dr. Emily Voigt's oral presentation where she will present new preclinical data on development of an intranasal RNA Covid vaccine. #mrnahealthconference #mrna22
AAHI
@AAHITweets
Join Dr. Maddy Jennewein on November 8th to learn more about incorporating adjuvant technology into RNA vaccines for stronger, more durable protection. #mrnahealthconference #mrna22
-
AAHI
@AAHITweets
A universal #covid19 vaccine is possible. @TheDHVI demonstrates their SARS-CoV-2 protein vaccine, when paired with an AAHI adjuvant, protects against multiple SARS-CoV-2 variants in a preclinical study published in @NatureComms go.nature.com/3U6XPKF
AAHI
@AAHITweets
The vaccine candidate combines Duke’s ferritin nanoparticle and AAHI’s 3M-052-AF adjuvant formulation, which when combined, provided strong COVID protection. Adjuvants boost the immune response for stronger protection against disease.
AAHI
@AAHITweets
“We are seeing that COVID variants of concern continue to emerge with greater transmissibility. As with the original Omicron variant, we find ourselves playing catch up,” says Dr. Corey Casper, CEO at AAHI. “A universal vaccine will put us one step ahead of the virus.”
-
AAHI
@AAHITweets
Immune imprinting makes it difficult to develop better vaccines, but an adjuvant may breakthrough imprinting by boosting your natural immune system. @ReporterGoodman points out it is not easy to add adjuvants to mRNA vaccines - we need a new approach www.cnn.com/2022/10/26/health/updated-boosters-omicron-im…
-
AAHI
@AAHITweets
We need broadly protective vaccines. Continued investment in next-generation vaccines is key to develop better vaccines and prepare us for future global health threats. www.cidrap.umn.edu/news-perspective/2022/10/new-vaccine-r…
-
AAHI
@AAHITweets
Public-private partnerships are fundamental to breaking down the barriers to equitable access to health solutions - awareness, affordatbility, and physical barriers, writes @kristine_gill fortune.com/2022/10/24/salesforce-global-health-divide-eq…
-
AAHI
@AAHITweets
People with immune disorders fear a winter of new omicron subvariants - continued research to develop universal vaccines that are stronger and more durable is necessary to protect high-risk populations. www.nbcnews.com/health/health-news/omicron-subvariants-po… via @nbcnews
-
AAHI
@AAHITweets
Do continued emerging variants of concern mean inevitable new boosters? Will we be left chasing the virus? @HelenBranswell highlights the concern in an interview iwth FDA's Peter Marks. #nextgenerationvaccines are needed to protect from current and future variants.
Matthew Herper
@matthewherper
“I would be lying to you if [I said] it doesn’t keep me up at night worrying that there is a certain chance that we may have to deploy another booster…”
@HelenBranswell interviews the FDA’s Peter Marks. www.statnews.com/2022/10/21/fdas-vaccines-chief-sees-poss… -
AAHI
@AAHITweets
We continue to play catch up to emerging variants of concern - a universal vaccine that protects us against current and future variants will put us one step ahead of the virus. Continued development of these next-generation vaccine solutions is critical. www.telegraph.co.uk/global-health/science-and-disease/swa…
-
AAHI
@AAHITweets
FDA authorizes booster shot for Novavax’s adjuvanted Covid-19 vaccine - giving the remaining 50% of Americans who have not received an initial RNA vaccine booster an alternative www.statnews.com/2022/10/19/fda-authorizes-booster-shot-f… via @statnews
-
AAHI
@AAHITweets
Booster shots are critical for sufficient protection against COVID19 and reiterate the continued importance of research and development of more durable and broadly protective vaccines.
-
AAHI
@AAHITweets
Join Dr. @ShanLuLiu1 tomorrow at the #hiv Vaccine Trial Network annual conference in Seattle to learn more about the safety and immunogenicity results of a Phase 1 clinical trial evaluating a 2nd generation polyvalent DNA #adjuvanted protein vaccine #hvtn
-
AAHI
@AAHITweets
AAHI partners with @txbiomed to develop innovative tuberculosis vaccine candidates for protection against the second leading infectious killer next to COVID-19 with a $3.5 million award granted by the @NIH www.txbiomed.org/news-press/news/tb-vaccine-aahi/
AAHI
@AAHITweets
AAHI and @txbiomed explore mix-and-match regimens of new adjuvanted protein TB vaccines with RNA TB vaccines administered by both a needle and nasal spray in genetically diverse mice as a model for the genetic diversity of the human population. #clinicallyrelevant
-
AAHI
@AAHITweets
AAHI and @UAlberta researchers explore the intricacies of a nasal spray vaccine for optimal protection against Amebiasis – evaluating spray pattern, plume geometry, and droplet size in the nasal cavity and lungs in both adults and children. @NIH @3M #uva www.sciencedirect.com/science/article/abs/pii/S0378517322…
AAHI
@AAHITweets
Amebiasis is an infectious disease common in low-income, tropical areas that is transmitted through contaminated food and water and poor hand hygiene. A nasal spray vaccine would be an efficient solution to protecting the areas most burdened by the disease.
-
AAHI
@AAHITweets
Despite COVID complications, @vaccine_HIV and @BrighamWomens successfully launched, recruited, and enrolled a Phase 1b HIV vaccine clinical trial despite pandemic complications. Learn how at the International Society for Vaccines conference today! isv-online.org
AAHI
@AAHITweets
The HIV vaccine candidate evaluates a polyvalent DNA protein (PDPHV) administered with and without AAHI's adjuvant fromulation, GLA-SE. Visit the @NIH's Vaccine Adjuvant Compedium profile to learn more about the TLR 4 agonist in a squalene emulsion vac.niaid.nih.gov/view?id=62
-
AAHI
@AAHITweets
We continue exploring a bivalent #covid19 vaccine in collaboration with @ImmunityBio and @Amyris that targets the S protein and the N protein, the non mutating part of the virus, to provide protection against future coronavirus variants.
ImmunityBio, Inc.
@ImmunityBio
Recently, @drpatrick spoke with @corinnepurtill to discuss our multivariant #covid19 vaccine candidate and clinical trials in South Africa. Read more about these types of vaccines via the @LATimes: lat.ms/3BIMtpF
-
AAHI
@AAHITweets
Researchers at @TheDHVI are one step closer to an HIV vaccine that will prevent infection. A new vaccine combining a novel HIV envelope protein with AAHI's @3M-052-SE adjuvant formulation protected primates who were exposed to HIV, published in @ScienceTM www.science.org/doi/10.1126/scitranslmed.abo5598?url_ver=…
-
AAHI
@AAHITweets
How nasal-spray vaccines could change the pandemic www.nature.com/articles/d41586-022-02824-3
-
AAHI
@AAHITweets
The three mottos in infectious disease: "The virus always wins. The virus is always a few steps ahead of us. Any vaccine strategy that requires us to catch up means we're always going to be behind." - Dr. Casper, CEO, tells @IBD_AGatlin at @IBDinvestors www.investors.com/news/technology/vaccine-stocks-pfizer-m…
-
AAHI
@AAHITweets
Preliminary data shows @baiyaphytopharm's plant-based #covid vaccine containing 3M-052-AF used with alum adjuvant formulation is safe in humans. Read more baiyaphytopharm.com/announces-preliminary-results-of-the-…
-
AAHI
@AAHITweets
Dr. Voigt is presenting now! Join us live to hear more about our RNA platform. us06web.zoom.us/j/86119141792?pwd=V2tWaW5oemdaUW5TeU1wLzd…
-
AAHI
@AAHITweets
Join Dr. Emily Voigt, Principal Scientist to discuss the development of our RNA platform that provides thermostability, cross-strain protection, and can be delivered up the nose on @fredhutch's COVID-19 Prevention Network www.covpnsciencetalks.org
-
AAHI
@AAHITweets
How Nasal Vaccines Could Transform the Pandemic @inthebubblepod
"...the patch that we need, to patch up the leak of the vaccines because once it gets in through our nasal mucosa or our oral mucosa upper airway, that's game over in infection" - @EricTopol
omny.fm/shows/in-the-bubble/how-nasal-vaccines-could-tran… -
AAHI
@AAHITweets
A recent preclinical study in @FrontiersIn found that "mix-and-match" #covid_19 vaccines trigger stronger and more durable immune responses. AAHI-SC2 RNA vaccine 'prime' and adenovirus vectored vaccine 'boost' from @ImmunityBio www.frontiersin.org/articles/10.3389/fimmu.2022.910136/full
-
AAHI
@AAHITweets
Can we really get better Covid vaccines? There are big hurdles, but some hope www.statnews.com/2022/07/27/can-we-really-get-better-covi… via @statnews
-
AAHI
@AAHITweets
Next-generation #covid vaccines that provide longer lasting, broad protection are being developed through collaboration with @ImmunityBio and @Amyris and can be advanced to reach those most in need in partnership with the #bidenadministration @WHCOVIDResponse
-
AAHI
@AAHITweets
From collaboration and compassion comes change.
ImmunityBio, Inc.
@ImmunityBio
Together with @AAHI & @Amyris, we've embarked on a path to develop 2nd gen RNA vaccines for #covid that provide broad, durable protection. A better future exists if the federal government acts to financially and scientifically support 2nd generation vaccines. @WHCOVIDResponse
-
AAHI
@AAHITweets
Three strategies for next-generation #covid vaccines:
1. Target more than just an S target for durable immunity
2. Engage T cell responses
3. Use adjuvants with protein vaccines
- Dr. Reddy, CMO,
@ImmunityBio
@WHCOVIDResponse -
AAHI
@AAHITweets
"Durability, breadth, acquisition, transmission." The holy grail of the two pillars of next-generation vaccines: pan-coronavirus and inhalable vaccines. - #drtonyfauci @WHCOVIDResponse
-
AAHI
@AAHITweets
As the world grapples with yet another #covid surge, scientists improve current vaccine technology to provide longer lasting and broad protection against current and emerging SARS-CoV-2 variants, ensuring global accessibility to hamper the emergence of new variants. #betterfuture
White House 46 COVID-19 Response Team Archived
@WHCOVIDRes46
HAPPENING NOW: Tune in here for the White House Summit on the Future of COVID-19 Vaccines, hosted by Dr. Ashish Jha and the White House COVID-19 Response Team. x.com/i/broadcasts/1MYxNnozEMyxw
-
AAHI
@AAHITweets
Tune in to the @WhiteHouse summit on next-generation #covid vaccines to discuss how more durable, broadly protective, and equitably accessible vaccine technology can efficiently protect us from the ongoing pandemic. #collaboration
ImmunityBio, Inc.
@ImmunityBio
Tomorrow, we are participating in the @WhiteHouse summit on next-generation #covid vaccines. Our vaccine candidates are designed to thwart future coronavirus variants and provide longer duration protection. Tune in here: pitc.zoomgov.com/webinar/register/WN_8Lx74G-PSYOwmdwfcnQ7AQ. @WHCOVIDResponse
-
AAHI
@AAHITweets
Global Institute Simplifies Vaccine Manufacturing for Developing World www.genengnews.com/topics/bioprocessing/global-institute-… via @GENbio
-
AAHI
@AAHITweets
Only 2 African countries have reached to 70% COVID-19 vaccination goal, 9 have yet to reach 10%. Tune in to the @ACTAccelerator Facilitation Council meeting to learn about efforts to improve health infrastructure in LMICs to protect from emerging threats www.who.int/news-room/events/detail/2022/07/06/default-ca…
-
AAHI
@AAHITweets
‘The tide is coming back’: Bracing for a new global health fight www.politico.com/news/2022/07/04/atul-gawandes-new-global… via @politico
-
AAHI
@AAHITweets
#adjuvants enable protection of our most vulnerable populations. CDC Panel Recommends Older Adults Receive Enhanced Flu Vaccine, Incl. Fluad Quadrivalent www.nasdaq.com/articles/cdc-panel-recommends-older-adults…
-
AAHI
@AAHITweets
Soapbark branches out to fill essential role in vaccine recipes. Sustainable sourcing processes are needed to for sufficient supply of this raw material. www.chemistryworld.com/news/soapbark-branches-out-to-fill…
-
AAHI reposted
Abraar Karan
@AbraarKaran
Interviewed for this @nytimes piece — yes, deaths remain low. But as I share here & shared on Twitter earlier this week, surges of infections are still a problem.
We must conquer the next challenge: stamping out *transmission*
www.nytimes.com/2022/06/20/health/covid-deaths-plateau.html -
AAHI reposted
Dr. Pat Soon-Shiong
@DrPatrick
As we have been saying for 2 years now …….T cells protect against COVID-19 in absence of antibody response | National Institutes of Health (NIH) #covid … www.nih.gov/news-events/nih-research-matters/t-cells-prot…
-
AAHI reposted
Global Health Strategies
@GHS
It’s simple. Vaccines save lives.
-
AAHI
@AAHITweets
Two-Step QS-21 Purification Simplifies Process for Greater Use www.genengnews.com/topics/bioprocessing/two-step-qs-21-pu… via @GENbio #sustainabledevelopment
-
AAHI
@AAHITweets
Analysis | Covid Boosters, Like Flu Shots, Need a Yearly Schedule www.washingtonpost.com/business/covid-boosters-like-flu-s…
-
AAHI
@AAHITweets
More than 1 in 5 adult Covid survivors in the U.S. may develop long Covid, a C.D.C. study suggests. Preventing initial infection must be an urgent priority to alleviate long-term symptoms. www.nytimes.com/2022/05/24/health/long-covid-infections.html
-
AAHI reposted
Eric Topol
@EricTopol
An outstanding review of the diverse and potent ways to establish mucosal immunity via nasal and oral vaccines
www.nature.com/articles/s41577-021-00583-2 @NatRevImmunol -
AAHI
@AAHITweets
Nasal COVID-19 vaccines help the body prepare for infection right where it starts – in your nose and throat theconversation.com/nasal-covid-19-vaccines-help-the-body… via @ConversationUS An informative interview with our valued partner, Mayuresh Abhyankar, at @UVA. @uvahealthnews
-
AAHI
@AAHITweets
Protection is still needed to halt the virus from spreading, prevent infection, and alleviate persistent long-term symptoms. #nextgeneration vaccines will provide a more sustainable solution to fight pandemics.
www.bloomberg.com/news/newsletters/2022-05-31/coronavirus… -
AAHI
@AAHITweets
Sweden recommends 5th COVID vaccine shot for those who are pregnant, over 65 or immunocompromised. A perpetual state of boosting. We need longer lasting vaccines. www.nydailynews.com/coronavirus/ny-covid-sweden-recommend…
-
AAHI reposted
Scientific American
@sciam
Experts address when the youngest children could be eligible for the shots, why that has taken so long, and more www.scientificamerican.com/article/when-will-kids-under-f…
-
AAHI
@AAHITweets
Vaccines administered up the nose can halt the virus in its tracks and prevent #infection and provide mucosal #immunity - key for respiratory infectious diseases. youtu.be/45T5OkZX6n0
AAHI
@AAHITweets
AAHI is hard at work with @BARDA to develop an intranasal #influenza RNA vaccine that is heat stable and can reach even low-resource areas of the world. #accessibility
-
AAHI
@AAHITweets
Interested in joining the Seattle non-profit biotech community? AAHI is hiring to innovate small molecule adjuvant formulations! Check out our website today.
-
AAHI reposted
Eric Topol
@EricTopol
In the United States, 136,000 new confirmed cases today brings the 7-day average >100,000. Real number is esitmated to be ~700,000. And >500 more people hospitalized. No reason for concern, right @CDCgov?
charts.medriva.com/us
erictopol.substack.com/p/the-covid-capitulation?s=w -
AAHI
@AAHITweets
Investment in improving the cold chain is good. Investment in eliminating the cold chain by developing temperature stable RNA vaccines is #sustainable.
newsdigest.ng/covid-why-africa-key/ -
AAHI
@AAHITweets
If you haven't already, make your way to Room 206 to hear more about AAHI's intranasally delivered SARS-CoV-2 vaccine candidate in just 5 minutes! #asgct22 @ASGCTherapy annualmeeting.asgct.org/abstracts/abstract-details?abstra…
-
AAHI
@AAHITweets
The Answer to Stopping the Coronavirus May Be Up Your Nose www.nytimes.com/2022/05/16/opinion/covid-nasal-vaccine.html
-
AAHI
@AAHITweets
Join us at #asgct22 in Room 206 from 4:40-4:45 tomorrow to learn more about a nasal vaccine for #covid19 to prevent infection. We can't wait to see you there!
-
AAHI
@AAHITweets
Our CEO, Dr. Corey Casper, discusses the SARS-CoV-2 booster vaccine landscape and the need for more sustainable solutions with @GailLdutton. @biospace www.biospace.com/article/more-durable-broader-spectrum-bo…
-
AAHI
@AAHITweets
We commit to bringing next-generation T-Cell vaccines that provide broad and durable protection to the people who need them most, especially those in low-resource areas of the world. #globalcovidsummit
@ImmunityBio -
AAHI
@AAHITweets
The different trajectories of Omicron and its subvariants are illustrating the challenge of maintaining immune defenses against the changing virus www.wsj.com/articles/omicrons-trajectory-shows-challenge-… via @WSJ
-
AAHI
@AAHITweets
"Globally, the World Health Organization reports that more than 50% of vaccines around the world are wasted." RNA vaccines can have a better stability profile to achieve vaccine equity. www.gavi.org/vaccineswork/how-data-can-reduce-waste-and-g…
-
AAHI
@AAHITweets
Investment in durable vaccine solutions will allow our response to deadly diseases like COVID to be more #sustainable.
www.cnn.com/2022/05/03/health/fda-annual-covid-vaccines-j… -
AAHI
@AAHITweets
Vaccines are the most effective tool to protect and improve lives around the world. Let’s continue to advocate for #globalhealth equity and collaborate to develop Next Generation Solutions | AAHI www.aahi.org/next-generation-solutions/
-
AAHI
@AAHITweets
Q&A: Start talking about mRNA vaccine access now, say experts www.scidev.net/global/spotlight/qa-start-talking-about-mr…
-
AAHI
@AAHITweets
RNA technology enabled the nation to develop safe #vaccines in less than a year - record time. The next generation of #rna vaccines can be more effective, flexible, and accessible.
-
AAHI
@AAHITweets
Adjuvants are a powerful tool to increase the efficacy and longevity of #vaccines. AAHI's adjuvant platform is part of the next generation of sustainable and effective molecules that boost immune responses to vaccines while reducing the burden on our precious natural resources.
-
AAHI
@AAHITweets
The #covid19 pandemic inspired great leaps in vaccine technology, allowing for fast and safe distribution. However, more innovation is needed to ensure access to these life-saving technologies around the world and to provide a #longlifeforall .
#worldimmunizationweek -
AAHI
@AAHITweets
Happy World Immunization Week!
This week we celebrate the importance of #vaccines, the life saving technology that protects us from the most deadly diseases. Vaccines give adults, children, and the next generation an opportunity to live a life free of illness and disease. (1/4)Post not available here, view on X
AAHI
@AAHITweets
There is still much work to be done to make vaccine technology accessible to all. Only 15.2 percent of people in low-income countries have received at least one dose of a COVID-19 vaccine. Removing the barriers to vaccine access requires a collaborative, pragmatic approach. (3/4)
AAHI
@AAHITweets
We look forward to sharing our research and development of next generation vaccine technology throughout the week.
Let’s use this week to encourage vaccination for all! (4/4)
#longlifeforall #worldimmunizationweek #vaccineswork -
AAHI
@AAHITweets
CEO Dr. Corey Casper recently spoke to @PharmaVoice about AAHI's self-amplifying RNA platform for infectious disease and cancer. He discussed our collaborations with industry partners to manufacture our technology for global access.
www.pharmavoice.com/news/mrna-pharma-Moderna-Pfizer-BioNt…
#longlifeforall
AAHI
@AAHITweets
mRNA vaccine technology has been pivotal in the battle against COVID-19 and demonstrates the capacity of the scientific vaccine community to protect us. This technology can be further developed to make more accessible, broadly neutralizing, and longer-lasting mRNA vaccines.
-
AAHI reposted
Life Science WA
@LifeScienceWA
#lsinw22 - Corey Casper, MD, MPH, CEO of @AAHITweets presents during the Public & Global Health company presentations
-
AAHI
@AAHITweets
Pan-coronavirus vaccine pipeline takes form www.nature.com/articles/d41573-022-00074-6
AAHI
@AAHITweets
"To really have a highly effective vaccine, you're going to need to be able to elicit both neutralizing antibodies and T cells," AAHI CEO Dr. Corey Casper tells @ElieDolgin at @NatRevDrugDisc
-
AAHI
@AAHITweets
Join us this Thursday at #lsinw2022 for a presentation about AAHI and our immune-enhancing platforms for next generation #vaccines and #immunotherapies to kick off the #globalhealth presentation session at 10am PST. lifesciencewa.org/events/life-science-innovation-northwes…
-
AAHI
@AAHITweets
#adjuvants may "trigger strong, long-lived antibody response." www.register-herald.com/region/why-we-cant-boost-our-way-…
-
AAHI
@AAHITweets
Join us at #lsinw 2022, Pacific Northwest's largest annual life science conference hosted by @LifeScienceWA. Register today!
lifesciencewa.org/events/life-science-innovation-northwes… -
AAHI
@AAHITweets
A more sustainable approach to pandemic response is necessary to combat emerging variants. Vaccines that are #accessible, #broadlyneutralizing, and #durable.
Tulio de Oliveira
@Tuliodna
New Omicron BA.4 & BA.5 detected in South Africa, Botswana, Belgium, Germany, Denmark, and U.K. Early indications that these new sublineages are increasing as a share of genomically confirmed cases in SA. No cause for alarm as no major spike in cases, admissions or deaths in SA
-
AAHI reposted
carolyn johnson
@Carolynyjohnson
The next leap in coronavirus vaccine development could be a nasal spray www.washingtonpost.com/health/2022/04/10/nasal-covid-vacc…
-
AAHI
@AAHITweets
$26M donation supports the development of adjuvant and RNA technology for temperature stable, broadly neutralizing, and long lasting vaccines that can reach all areas of the world. @schubertcm
www.geekwire.com/2022/seattle-nonprofit-developing-covid-… via @GeekWire -
AAHI
@AAHITweets
We are grateful to receive a $26 million donation to continue development of next generation vaccines and immunotherapies addressing global unmet needs #nextgeneration #globalhealth
www.businesswire.com/news/home/20220411005316/en -
AAHI
@AAHITweets
"An equitable roadmap for ending the COVID-19 pandemic" @NatureMedicine go.nature.com/3x5VUh7
-
AAHI
@AAHITweets
When three shots aren't enough, more #effective, #durable vaccine technology is needed to reduce the number of boosters needed to protect us. Adjuvant technology strengthens the body's natural immune response to disease, a more efficient #vaccine solution. www.aahi.org/products-services/adjuvant-platform/
-
AAHI
@AAHITweets
"Speed and time are of the essence." Dylan Matthews at @voxdotcom outlines why and how we can prepare for the next pathogen that will infect us at an exponential rate through lessons learned from the #covid19 pandemic. www.vox.com/22937351/next-pandemic-vaccine
-
AAHI
@AAHITweets
The Chairman of our Board of Directors, @drpatrick discusses the vaccine developments in Africa that are enabling the continent to be self-reliant - and how the rest of the world will benefit from them. foreignaffairs.house.gov/hearings?ContentRecord_id=7EBF60…
-
AAHI
@AAHITweets
Our RNA platform can be readily lyophilized to provide 6+ month stability at standard refrigerator temperatures with room temperature deviations. We are eliminating the deep-cold chain requirements of current RNA vaccines. @MolTherapy www.sciencedirect.com/science/article/pii/S2329050122000390
AAHI
@AAHITweets
A temperature stable vaccine is critical to enable equitable access to the vaccine and our ability to rapidly respond to emerging threats around the world.
-
AAHI
@AAHITweets
Rapid response to emerging threats is hampered by the deep cold chain required for global distribution of current RNA vaccines and delays are fatal. @Nature Next-gen RNA vaccines can be stored in simple refrigeration with room temp deviations. go.nature.com/3qKevLp
-
AAHI
@AAHITweets
As the #omicron variant spreads quickly through China, the need to close the #covidgap with low-and-middle income countries and develop equitably accessible solutions. @DukeGHI's new policy paper outlines 4 steps to avoid an uncontrollable global outbreak bit.ly/3ITO38l
-
AAHI
@AAHITweets
We are excited to announce that after nearly 3 decades of innovation, product development, and manufacturing, IDRI has re-launched as the Access to Advanced Health Institute, AAHI, reflected in the branding and name changes on this page.
AAHI
@AAHITweets
Read more about the launch of AAHI here: www.businesswire.com/news/home/20220302005470/en/Infectio…
-
AAHI reposted
CBC News
@CBCNews
The development of a so-called universal coronavirus vaccine offering broad, long-term protection needs to be the focus of an intense effort, scientists suggest. www.cbc.ca/1.6284038
-
AAHI reposted
ThinkOutLoud on OPB
@OPBTOL
Federal health officials recently announced that COVID-19 vaccine booster shots will be available to adults in the U.S. in September. Corey Casper is the CEO of the Infectious Disease Research Institute (@IDRIsocial). He joins us.
www.opb.org/article/2021/08/24/the-science-behind-booster… -
AAHI
@AAHITweets
Read more about the study results published in the May 10th edition of @Nature here: www.idri.org/wp-content/uploads/2021/05/IDRI-Pan-Vaccine-…
-
AAHI
@AAHITweets
A pan-coronavirus vaccine is needed to help end COVID-19 & be ready for the next pandemic. An effective coronavirus vaccine remains out of reach for millions around the world, & this groundbreaking technology could provide broad protection against coronaviruses no & in the future
Axios
@axios
New science is breathing fresh life into the idea of a vaccine that works against all coronaviruses, including ones that could cause future pandemics. www.axios.com/the-hurdles-to-creating-a-universal-coronav…
-
AAHI
@AAHITweets
Our CEO, Dr. Corey Casper, spoke with @axios' @caitlinnowens about the significance of our pan-coronavirus vaccine study published last month in @Nature. The global COVID-19 pandemic comes amidst an alarming rise of coronavirus-related outbreaks over the past decades.
Axios
@axios
New science is breathing fresh life into the idea of a vaccine that works against all coronaviruses, including ones that could cause future pandemics. www.axios.com/the-hurdles-to-creating-a-universal-coronav…
-
AAHI
@AAHITweets
The global COVID-19 pandemic comes amidst an alarming rise of coronavirus-related outbreaks over the past decades. A pan-coronavirus vaccine is needed to help end the fight against COVID-19 and be ready for the next pandemic.
-
AAHI
@AAHITweets
#fauci highlights IDRI pan-coronavirus vaccine candidate @WHCOVIDResponse press briefing nam12.safelinks.protection.outlook.com?url=https://www.wh…. Nature study go.nature.com/3wbaIax, showed IDRI’s formulation of 3M’s adjuvant compound, induced neutralizing antibodies 4 pandemic & pre-emergent coronaviruses.
-
AAHI
@AAHITweets
CEO, Corey Casper, spoke at @WhyWeVax VaxTalks Round Table discussing COVID19 variants and vaccines (16:30 mark) #covid19 #covidvariant #vaccineswork www.youtube.com/watch?v=Bmpx_RbTqo4
-
AAHI
@AAHITweets
IDRI, Duke Vax Institute, 3M Partner On Adjuvant COVID Vax shar.es/aoPf63
-
AAHI
@AAHITweets
The WHO declared a coronavirus variant first identified in India, B.1.617, as a “variant of concern,” the agency’s fourth such designation.
Adjuvants are found to be a critical vaccine component in developing a potential pan-vaccine.
www.wsj.com/articles/coronavirus-strain-found-in-india-is… via @WSJ -
AAHI
@AAHITweets
New COVID-19 Vaccine on the Block Displays Multi-Variant Potential | BioSpace www.biospace.com/article/new-vaccine-candidate-shows-pote… #jobs
-
AAHI reposted
Eric Topol
@EricTopol
Just published @nature: 1st step towards a pan-coronavirus mRNA nanoparticle vaccine with activity against all major #sarscov2 variants, #sarscov1, bat-CoV, with potent effect in macaques
www.nature.com/articles/s41586-021-03594-0 -
AAHI
@AAHITweets
A new adjuvanted vaccine candidate demonstrates COVID pan-vaccine potential. Results published today in @nature on a @TheDHVI-led study, shows the adjuvant, IDRI's formulation of @3M's compound, provided a critical boost to induce the robust protection. www.nature.com/articles/s41586-021-03594-0
-
AAHI
@AAHITweets
#worldimmunizationweek is an important reminder that in our connected world, a viral outbreak anywhere is a threat to all of us. The development of safe and effective vaccines is critical to improving the health and wellbeing of children and adults around the globe. #vaccineswork
-
AAHI
@AAHITweets
Vaccines offer us the easiest path back to normal as we fight to end this global pandemic. At IDRI, we are focused on ensuring global, equitable access to safe and effective vaccines for people around the globe. #vaccineswork #worldimmunizationweek
-
AAHI
@AAHITweets
IDRI's Dr. Emily Voigt speaks today @NFIDvaccines' 2021 annual conference on how the global community can achieve equitable COVID-19 vaccine distribution & how innovative vaccine delivery technologies can strengthen future pandemic vaccination efforts. acvr.nfid.org
-
AAHI
@AAHITweets
This week we recognize #worldimmunizationweek2021! @WHO is working with countries around the world to raise awareness of the value of vaccines and immunization programs. #vaccineswork
-
AAHI
@AAHITweets
There is still time to register if you are interested in attending #lsinw2021 conference! You can go to the @LifeScienceWA site and sign up here: lifesciencewa.org/events/life-science-innovation-northwest/
-
AAHI
@AAHITweets
Tomorrow our CEO, Dr. Corey Casper, will be presenting at #lsinw2021, the Pacific Northwest's largest annual life science conference. Dr. Casper will be addressing IDRI's new technologies for accessible, durable and broadly protective coronavirus vaccines.
-
AAHI
@AAHITweets
Come join us at #lsinw2021 March 30th. Dr. Corey Casper, CEO, will present technology developed by IDRI that can play a critical role in ending the COVID-19 pandemic and preparing the world for the next one. Thank you @LifeScienceWA for the opportunity! www.idri.org/wp-content/uploads/2021/03/LSINW-Media-Advis…
-
AAHI
@AAHITweets
There is still no cure to COVID-19. If you have a friend or family member facing limited options, ask your physician about @Celularity's, CYNK-001-COVID clinical trial, strengthening the immune response by injecting Natural Killer cells. Learn more at www.cynkcovid.com.
-
AAHI
@AAHITweets
365 days ago, @WHO acknowledged COVD-19 as a global pandemic enabling the acceleration of innovation in RNA vaccine technology. Continued investment in RNA platforms is needed to quickly adapt to novel or mutant viral strains. www.wsj.com/video/the-science-behind-why-new-covid-varian…
#rnavaccineplatform #idri -
AAHI
@AAHITweets
Dr. Corey Casper, CEO, tells @USATODAYhealth that the next challenge we face in this pandemic is vaccine hesitancy, ensuring that everyone is willing and able to get vaccinated, so vaccine technologies developed in record time can protect our world.
www.usatoday.com/story/news/health/2021/03/04/covid-19-va… -
AAHI
@AAHITweets
We are proud to announce the award of a federal grant to our very own Dr. Emily Voigt! Her team will be focused on innovative development of better, stronger RNA-based vaccines, such as the ones currently in use against #covid. Read more here: www.idri.org/wp-content/uploads/2021/03/Voigt-DoD-Grant-P…
-
AAHI
@AAHITweets
IDRI's RNA vaccine platform shows promise from preliminary pre-clinical data as we codevelop a covid vaccine candidate with @Amyris. RNA vaccines are the future for combatting the world's deadliest diseases.
investors.amyris.com/2021-02-22-Amyris-Announces-Positive…
#platformtechnology -
AAHI reposted
FP2030
@FP2030Global
Happy #womeninscience Day!
Let’s smash stereotypes, defy gender bias and defeat discrimination that holds women and girls back in Science, Tech, Engineering and Math. 👩🔬👩🚀 #generationequality via @UN_Women -
AAHI
@AAHITweets
RNA vaccine technology is highly robust and can be rapidly applied to viral mutants. Dr. Emily Voigt, manager of IDRI's RNA vaccine platform, tells @inversedotcom it takes less than an hour to design a vaccine specifically for the new variant! #fightcovid
www.inverse.com/mind-body/covid-variant-vaccine-tweak -
AAHI
@AAHITweets
IDRI is thrilled to be partnered with Worcester HIV Vaccine who received clearance from FDA to explore different vaccination designs for their HIV vaccine candidate. Our immune-boosting adjuvant continues to show protection against intractable diseases. www.whvaccine.com/fda-clears-worcester-hiv-vaccine-invest…
-
AAHI
@AAHITweets
New mRNA vaccine technology is promising, but not perfect. IDRI CEO shares with @sciam the perpetual challenges we face without the expected lasting antibodies, an indication of strong and durable protection. www.scientificamerican.com/article/new-covid-vaccines-nee…
-
AAHI
@AAHITweets
COVID mutations that manifest in animals and are contracted by humans pose a new threat. IDRI CEO Dr. Casper conveys concern for the lack of immunity humans have to the likely mutations of SARS-CoV-2. #covidmutation khn.org/news/at-risk-of-extinction-black-footed-ferrets-g…
-
AAHI reposted
ThinkOutLoud on OPB
@OPBTOL
Why do the new vaccines have to stay SO COLD? LISTEN: www.opb.org/article/2020/12/18/why-delivering-the-covid-1…
-
AAHI
@AAHITweets
An unprecedented pandemic response with an mRNA vaccine poses unprecedented challenges. IDRI's Dr. Corey Casper discusses the cold-chain challenges with @DaveMillerOPB @OPBTOL and the investment needed in specific heat stable technologies.
www.opb.org/article/2020/12/18/why-delivering-the-covid-1… -
AAHI
@AAHITweets
RNA vaccine technology requires a heat stable solution for global access. Our work in shoring up this supply speedbump stands to expedite the current distribution plans.
-
AAHI
@AAHITweets
Modern medical innovation needs non-profit involvement to ensure global accessibility -- a key tenet of IDRI's core mission.
-
AAHI
@AAHITweets
Multinational regulatory approval for #covid-19 #vaccines highlights the need for global accessibility to ensure efficacy.
-
AAHI
@AAHITweets
#vaccinations can be daunting. Here's why you should get one anyway.
www.cdc.gov/vaccines/parents/why-vaccinate/vaccine-decisi… -
AAHI
@AAHITweets
IDRI's Chris Fox spoke with @MelodyMV @Cenmag about shark-based squalene and its history with adjuvants, and why we've partnered with @amyris to find a synthetic alternative not just for the #covid vaccine, but for vaccine development of the future.
cen.acs.org/pharmaceuticals/vaccines/hunt-alternatives-sh… -
AAHI
@AAHITweets
Dr. Casper spoke with @USATODAY on how many vaccines never make it past the first round of tests, let alone to patients, highlighting the unique success of RNA candidates for #covid. www.usatoday.com/story/news/health/2020/12/09/when-pfizer…
-
AAHI
@AAHITweets
Candice Decaire has a history of successfully motivating both business and legal teams and is experienced in a wide variety of technological fields, from life sciences to medical devices. IDRI is excited to welcome her to the role of General Counsel!
www.prnewswire.com/news-releases/seattles-infectious-dise… -
AAHI
@AAHITweets
Yes, the vaccine candidates for Covid have been developed in record time. No, that doesn't mean we should be more alarmed about them.
www.npr.org/sections/coronavirus-live-updates/2020/11/30/… -
AAHI
@AAHITweets
Mark Fischetti and @jlswann's breakdown of the logistics in deploying a new RNA vaccine in @sciam highlights the challenges presented by thermostability and the need for a simplified supply chain.
www.scientificamerican.com/article/the-covid-cold-chain-h… -
AAHI
@AAHITweets
We talked with @Kiro7 about how our cell therapy treatment for #covid patients is expanding. With safety confirmed, we're seeking participants to help us complete Phase 1. Learn more here - www.kiro7.com/news/local/seattle-researchers-expand-human…
-
AAHI
@AAHITweets
Watch: IDRI's Dr. Casper and @King5Seattle discuss recent success in determining the safety of #covid clinical trials as we work with @Celularity to improve the immune response to the disease. www.king5.com/article/news/health/coronavirus/seattle-bas…
-
AAHI
@AAHITweets
For #worldaidsday we're standing with the scientific community, health workers, and patients alike as we continue working to develop a vaccine.
-
AAHI
@AAHITweets
This #worldaidsday, we're encouraged by progress in the battle against AIDS through our collaborations with @3M and @EmoryVaccineCtr developing an HIV vaccine. Adjuvants like 3M-052 allow solutions to previously intractable diseases to become a reality. www.eurekalert.org/pub_releases/2020-06/ehs-nas061920.php
-
AAHI
@AAHITweets
Independent confirmation of trial safety is key to our confidence in moving forward. If you or a loved one are looking for opportunities to fight #covid19, visit www.idri.org/trials/ to learn more about the CYNK-001 trial and begin consulting with your physician.
Celularity Inc. (NASDAQ:CELU)
@celularity
Celularity Announces Positive DMC Safety Review and Continuation of its Phase I/II CYNK-001-COVID-19 (CYNKCOVID) Study www.prnewswire.com/news-releases/celularity-announces-pos…
-
AAHI
@AAHITweets
With COVID-19 cases rapidly on the rise in Washington state, our community must remain vigilant in our collective efforts to stop the spread of the virus and protect our frontline healthcare workers as we await a safe vaccine. www.seattletimes.com/life/what-you-can-and-cant-do-follow…
-
AAHI
@AAHITweets
"We need to get ahead of this now before we're faced with major ecological costs." Concerns raised by oceanography expert Dr. @Enric_Sala are part of why IDRI's partnership with @Amyris to develop a sustainable alternative is crucial.
torontosun.com/news/local-news/potential-covid-19-vaccine… -
AAHI
@AAHITweets
How will the scientific community secure the squalene needed for the adjuvants in certain COVID-19 vaccine candidates, and why are more sustainable, synthetic alternatives not being more widely discussed?
www.usatoday.com/story/news/health/2020/10/15/covid-19-va…
#covid19 #vaccinedevelopment #squalene #adjuvant -
AAHI
@AAHITweets
Thank you to @UWMadison for the fantastic profile on Dr. Emily Voigt and her work as the head of IDRI’s new RNA Vaccine team. Read more here: www.uwalumni.com/news/one-step-ahead/
-
AAHI
@AAHITweets
It's more important than ever to get a flu shot this year since our flu season overlaps with the COVID-19 pandemic. By getting your flu vaccine, you protect yourself and others and save valuable hospital resources needed to treat those with COVID-19.
-
AAHI
@AAHITweets
It's International #infectionprevention Week @APIC, and we're celebrating Infection Prevention specialists working around the globe to fight the global coronavirus pandemic. Thank you for your efforts! professionals.site.apic.org
-
AAHI
@AAHITweets
Some COVID-19 vaccine candidates under development must be stored at extremely cold temperatures, and others utilize rare ingredients. How will we overcome these challenges in the race for a vaccine? Read more from @nytimes www.nytimes.com/2020/09/18/business/coronavirus-covid-vac…
-
AAHI
@AAHITweets
Thank you to @AlliantIns's Seattle Office for your generous support of IDRI!
-
AAHI
@AAHITweets
Thank you again to @ORHealthForum for including IDRI's Dr. Casper in your event last week! www.oregonhealthforum.org
-
AAHI
@AAHITweets
Register today for the @ORHealthForum Livestream on 10/1. Hear from experts including IDRI's Dr. Corey Casper as they discuss vaccine development efforts here in the Pacific Northwest. www.oregonhealthforum.org/2020/09/02/october-1-2020-how-w…
-
AAHI
@AAHITweets
Dr. Casper recently spoke with @MarketWatch about the differences between the four coronavirus vaccines in late-stage studies. www.marketwatch.com/story/there-are-four-coronavirus-vacc…
#infectiousdisease #idri #covid19 #coronavirus #vaccinedevelopment #vaccine -
AAHI
@AAHITweets
IDRI's adjuvant technology may be the missing piece that will help close the vaccine manufacturing gap. Read more about this hurdle in the vaccine development process in Politico's article: www.politico.com/news/2020/08/12/coronavirus-vaccine-chal…
-
AAHI
@AAHITweets
Could the next COVID-19 vaccine be on the horizon? Several different treatments will likely be needed to ensure the safety of our diverse global population, so the IDRI team is hard at work with partners to pursue multiple vaccines. Read more at idri.org.
-
AAHI reposted
The Seattle Times
@seattletimes
We’re updating this page with the latest news about the COVID-19 pandemic and its effects on the Seattle area, the Pacific Northwest and the world, including stats about the spread of the coronavirus in Washington state. st.news/3kOfUeT
-
AAHI
@AAHITweets
Today is world patient safety day! We must recognize the hard work and dedication of all health care providers in the fight against COVID-19, and efforts to protect those on the front lines. www.who.int/news-room/events/detail/2020/09/17/default-ca…
-
AAHI
@AAHITweets
Thank you to @GeoffBakerTIMES and the @seattletimes for speaking with @IDRItweets Senior Clinical Trial Manager Alan Lew about our CYNK-001 clinical trial! www.seattletimes.com/seattle-news/health/a-covid-19-treat…
-
AAHI
@AAHITweets
We’re thrilled to announce that the first patient in our clinical trial with partner @celularity was administered treatment via an infusion of CYNK-001 immune cells — Natural Killer cells — for more information on this trial, including eligibility visit www.idri.org/trials/.
-
AAHI
@AAHITweets
Dr. Corey Casper recently spoke to @KING5Seattle to offer expert commentary on plasma treatments being offered for COVID-19.
#infectiousdisease #idri #covid19 #coronavirus #plasma
www.king5.com/article/news/health/coronavirus/seattle-inf… -
AAHI
@AAHITweets
IDRI's own Christian Devine, Dr. Christopher Fox, and Microfluidics recently contributed to an article published by MDPI on IDRI's solution to scale SE manufacturing for pandemic response.
www.mdpi.com/1424-8247/13/8/168/htm?hss_channel=lcp-76171
#pandemicresponse #scalability #manufacturing #idri #squalene -
AAHI
@AAHITweets
IDRI's adjuvant technology may be the missing piece that will help close the vaccine manufacturing gap. Read more about this hurdle in the vaccine development process in Politico's article from last week: www.politico.com/news/2020/08/12/coronavirus-vaccine-chal…
#infectiousdisease #covid19 #idri #pandemicresponse -
AAHI
@AAHITweets
The initial results of @celularity Inc.'s COVID-19 immunotherapy trial are 'promising.' Learn more about the trial and the global coronavirus vaccine and therapeutics trial arena from Dr. Corey Casper, CEO.
www.king5.com/article/news/health/coronavirus/seattle-res… -
AAHI
@AAHITweets
Low NK cell counts have been associated with severe cases of COVID-19. IDRI and @celularity's study will measure whether delivering NK cells will push the body to mount an immune response against the virus. Visit us for info and requirements to participate.
#clinicaltrial -
AAHI
@AAHITweets
Human trials are now OPEN for our novel study for the treatment of COVID-19 in collaboration with @celularity. Visit clinicaltrials.gov/ct2/show/NCT04365101?term=CYNK001&draw… for more information on this study, including requirements to participate.
#infectioudisease #idri #clinicaltrial #covid19 #immunotherapy -
AAHI
@AAHITweets
IDRI believes that adjuvants are a critical part of an outbreak response. They improve the body's immune response, broaden and lengthen the duration of vaccine protection and reduce the amount of antigen needed for production.
#infectiousdisease #idri #adjuvants #vaccine -
AAHI
@AAHITweets
Meet Emily Voigt, Ph.D. Dr. Voigt is paving the way for women in the vaccine technology space, and we're thrilled to have her leading our RNA Vaccine Team!
#infectiousdisease #idri #rnavaccines #vaccinetechnology #vaccines #zika #yellowfever #womeninscience -
AAHI
@AAHITweets
As hospitalizations for COVID-19 rise just slightly here in WA the push for a viable vaccine candidate continues www.seattletimes.com/seattle-news/washington-state-corona…
-
AAHI reposted
Governor Bob Ferguson
@GovBobFerguson
It’s not every day we can save lives and help businesses reopen with a piece of fabric. But we can today.
Wear a face covering. Help beat this virus.
#maskupwa -
AAHI
@AAHITweets
IDRI’s immune-enhancing adjuvant formulation, 3M052-Alum, proves successful in extending immunity against HIV. Proud to partner with Mark Tomai at @3M, who discovered the 3M052 adjuvant, Dr. Kastur & Dr. Ahmed at the Emory Vaccine Center @emoryhealthsci www.eurekalert.org/pub_releases/2020-06/ehs-nas061920.php
-
AAHI
@AAHITweets
IDRI is hiring! We are seeking a motivated Project Manager to work collaboratively with our scientific staff . Apply today to be part of our efforts to fight COVID-19 and other infectious diseases. Visit secure3.entertimeonline.com/ta/90580.careers?rnd=WZX&Show…
#nowhiring #applytoday #careers #covid19 -
AAHI reposted
Hope Rises International
@hoperisesintl
Great work from @BCM_TropMed @TexasChildrens @PATHtweets & @IDRItweets, extending their partnership to vial #covid19 #vaccine to prepare for Phase 1 trial. @PeterHotez @mebottazzi #infectiousdiseases #ntds #coronavirus
www.bcm.edu/news/baylor-texas-childrens-to-accelerate-cov… -
AAHI
@AAHITweets
Thank you to @geekwire’s @b0yle for capturing IDRI’s contribution to developing a COVID-19 vaccine through our partnership with @BCM_TropMed and @PATH. www.geekwire.com/2020/infectious-disease-research-institu…
-
AAHI
@AAHITweets
IDRI is pleased to be partnering with the talented virologists at @BCM_TropMed and @TCHGlobalHealth and vaccine experts at @PATHtweets on the development of an effective and safe vaccine to prevent infection with SARS-CoV-2. @mebottazzi www.idri.org/wp-content/uploads/2020/06/IDRI-Baylor_Relea… #covid19 #vaccine
-
AAHI reposted
Governor Bob Ferguson
@GovBobFerguson
It’s Thursday morning. Washington is beautiful. And we are going to beat this virus.
NWS Seattle
@NWSSeattle
Colorful views from our roof this morning to brighten your day....or to end your night, as is the case for us. #wawx #sunrise
-
AAHI reposted
The New Yorker
@NewYorker
Larry Kramer has died, at 84 years old. “There is no question in my mind that Larry helped change medicine in this country,” Anthony Fauci said in a 2002 Profile of the activist and author. nyer.cm/whb0Gua
-
AAHI
@AAHITweets
Thank you again to @RAINincubator for featuring Dr. Christopher Fox as this month's Superhero of Science!
www.facebook.com/RAINIncubator/videos/vb.289013668128539/…
#rainincubator #infectiousdisease #idri #vaccine #adjuvants #lecture #superheroofscience -
AAHI
@AAHITweets
"As long as we don't cut scientific corners, a vaccine might be coming relatively soon," states Chris Fox, our VP Formulations tells @inversedotcom. Check out the full article to find out more about COVID-19 vaccine trials underway.
www.inverse.com/mind-body/coronavirus-vaccine-candidates-… -
AAHI
@AAHITweets
The world mobilizes to increase the supply of ventilators. Dr. Corey Casper, CEO, tells @KUOW our efforts to decrease demand. Take a listen. www.kuow.org/stories/seattle-research-institute-launches-…
-
AAHI reposted
FHI 360
@fhi360
@FHI360 is proud to announce @FHIClinical’s partnership with Infectious Disease Research Institute (@IDRItweets). The partnership will provide full-service CRO capabilities for an #immunotherapy trial to combat moderate to severe cases of #covid19.
totaltrials.com/news-item/fhi-clinical-providing-full-ser… -
AAHI
@AAHITweets
Full speed ahead. www.seattletimes.com/seattle-news/seattle-institutes-coro…



















































































